Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Comment by davgroon Sep 09, 2022 11:04pm
119 Views
Post# 34953739

RE:RE:Alternative Trading Systems (ATS)

RE:RE:Alternative Trading Systems (ATS)
Duster340 wrote: what was total volume today then if trades register on the ATS, according to stockhouse it was 11,200 obviously not cause that's what it was before i bought shares.


Total volume for ATE today was 31,967 shares, not the 11,200 stated by Stockhouse.


T:ATE - ANTIBE THERAPEUTICS INC. J - https://www.antibethera.com
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
ATE - T   7.5 0.62 · 0.64 4.0 0.63 +0.01 1.6 32.0 19 20 0.63  0.63  0.62 1.30  0.56 15:42:28 17:12 15 min RT 2¢
TSX - T 7.5 0.62 · 0.64 4.0 0.63 +0.01 1.6 11.2 7 7 0.63  0.63  0.63 1.30  0.56 13:05:42   15 min
Alpha - A   0.63 +0.01 1.6 17.5 11 6 0.63  0.63  0.62   15:42:28   15 min
Omega - O   0.62     2.5 2 1 0.62  0.62  0.62   14:28:37   15 min
Pure - P   0.62     0.5 0 3        Jul 18   15 min
CXD - D   0.62     0.1   1        Jan 26   15 min
TriAct - M   0.62     0.3 0 2        Sep 09-20   15 min

<< Previous
Bullboard Posts
Next >>